Pulmonary Pharmacology and Therapeutics

SJR Rank #6,679H-index: 87SJR: 0.819Best quartile: Q2APC: US$3,730
Journal website: aims, scope and author guidelines
Publisher

Academic Press

Country

United States

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Biochemistry (medical)Q2
  • Medicine (miscellaneous)Q2
  • Pharmacology (medical)Q2
  • Pulmonary and Respiratory MedicineQ2

Areas: Medicine

Most published research topics

Asthma and respiratory diseasesRespiratory and Cough-Related ResearchChronic Obstructive Pulmonary Disease (COPD) ResearchInhalation and Respiratory Drug DeliveryRespiratory Support and MechanismsNeonatal Respiratory Health ResearchPulmonary Hypertension Research and TreatmentsInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisDiverse Scientific and Economic StudiesHuman auditory perception and evaluation

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs03570105140

Documents per Year

20222025010203040

Detailed Information

ISSN

1094-5539, 1522-9629

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

3.77

References per Document

39.74

Coverage

1997-2026

Scope

Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews. Research Areas Include: • All major diseases of the lung • Physiology • Pathology • Drug delivery • Metabolism • Pulmonary Toxicology.

Metrics from SCImago Journal Rank 2025. View on SCImago